Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients’ and clinicians’ perspectives after a 12-month randomized controlled trial
Abstract Background A randomized controlled trial ‘Money for Medication’(M4M) was conducted in which patients were offered financial incentives for taking antipsychotic depot medication. This study assessed the attitudes and ethical considerations of patients and clinicians who participated in this...
Main Authors: | Ernst L. Noordraven, Maartje H. N. Schermer, Peter Blanken, Cornelis L. Mulder, André I. Wierdsma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12888-017-1485-x |
Similar Items
-
The effect of financial incentives on patients’ motivation for treatment: results of “Money for Medication,” a randomised controlled trial
by: Ernst L. Noordraven, et al.
Published: (2018-05-01) -
A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers
by: Demet Sağlam Aykut, et al.
Published: (2018-07-01) -
Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial
by: Ernst L. Noordraven, et al.
Published: (2018-09-01) -
Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation
by: Noordraven EL, et al.
Published: (2016-02-01) -
Antipsicóticos de ação prolongada no tratamento de manutenção da esquizofrenia: Parte I. Fundamentos do seu desenvolvimento, benefícios e nível de aceitação em diferentes países e culturas
by: Luiz Paulo de C. Bechelli